EMERYVILLE, Calif. (AP) _ Ligand Pharmaceuticals Inc. (LGND) on Wednesday reported a first-quarter loss of $15.4 million, after reporting a profit in the same period a year earlier.On a per-share basis, the Emeryville, California-based company said it had a loss of 91 cents. Earnings, adjusted for one-time gains and costs, were 58 cents per share.The drugmaker posted revenue of $45.7 million in the period._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LGND at https://www.zacks.com/ap/LGND